Target intelligence / Profile preview

Inhibitor of nuclear factor kappa-B kinase regulatory subunit gamma (NEMO)

Target
NEMO
Molecular classification
Scaffold protein, Regulatory subunit, Adaptor protein
01

Overview

Inhibitor of nuclear factor kappa-B kinase regulatory subunit gamma (IKBKG), commonly known as NF-kappa-B essential modulator (NEMO) or IKKγ, is a non-catalytic scaffold protein that serves as the regulatory subunit of the IκB kinase (IKK) core complex. It plays an indispensable role in the canonical NF-κB signaling pathway, which is a master regulator of immune responses, inflammation, cell survival, and development. Upon stimulation by proinflammatory cytokines (such as TNF-α and IL-1β) or pathogen-associated molecular patterns, NEMO binds to polyubiquitin chains and recruits the catalytic subunits IKKα and IKKβ, facilitating their activation. This leads to the phosphorylation and subsequent proteasomal degradation of IκBα, allowing NF-κB dimers to translocate to the nucleus and drive gene transcription.\n\nDysregulation of NEMO is heavily implicated in chronic inflammatory diseases, autoimmune disorders, and various cancers, while genetic mutations in the IKBKG gene cause rare X-linked disorders such as incontinentia pigmenti and anhidrotic ectodermal dysplasia with immunodeficiency. Consequently, NEMO has emerged as an attractive therapeutic target. Pharmacological strategies primarily focus on disrupting the protein-protein interaction between NEMO and the catalytic IKK subunits using NEMO-binding domain (NBD) peptides or small-molecule mimetics (e.g., SR12343, Shikonin), thereby selectively blocking stimulus-induced canonical NF-κB activation while sparing basal, non-canonical signaling to minimize systemic toxicity.

Other names
NF-kappa-B essential modulatorInhibitor of nuclear factor kappa-B kinase subunit gammaIKK-gammaIKKGFIP-3FIP3IKKAP1IP1IP2IPD2ZC2HC9
02

Mechanism of action

Disruption of the protein-protein interaction between NEMO and IKKβ/IKKα to prevent IKK complex assembly and subsequent canonical NF-κB activation

03

Biological functions

Signal transductionImmune responseInflammationApoptosisCell survivalCell proliferation
04

Disease associations

InflammationCancerInfectionAutoimmune diseaseNeurodegenerative diseaseIncontinentia pigmentiEctodermal dysplasia
05

Safety considerations

ImmunosuppressionIncreased susceptibility to infectionsHepatotoxicitySystemic toxicity from complete NF-κB blockadeImpaired tissue regeneration
06

Interacting drugs

NEMO-binding domain peptide

4 more in the full profile.

07

Biomarkers

Phosphorylated IκBαPhosphorylated p65IL-6 levelsTNF-α levelsIKBKG mutation status

Beyond the preview

Go deeper on Inhibitor of nuclear factor kappa-B kinase regulatory subunit gamma (NEMO).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Inhibitor of nuclear factor kappa-B kinase regulatory subunit gamma (NEMO).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call